These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8150596)

  • 21. The viral genome in experimental murine Coxsackievirus B3 myocarditis: a Northern blotting analysis.
    Okada I; Matsumori A; Kawai C; Yodoi J; Tracy S
    J Mol Cell Cardiol; 1990 Sep; 22(9):999-1008. PubMed ID: 2177795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis.
    Huber SA; Graveline D; Born WK; O'Brien RL
    J Virol; 2001 Jul; 75(13):5860-9. PubMed ID: 11390587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of viral RNA in mouse tissues during acute phase of coxsackievirus B5 infection.
    Moon MS; Joo CH; Hwang IS; Ye JS; Jun EJ; Lee HS; Kim D; Lee MJ; Lee H; Kim YK
    Intervirology; 2005; 48(2-3):153-60. PubMed ID: 15812189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates.
    Beck MA; Shi Q; Morris VC; Levander OA
    Nat Med; 1995 May; 1(5):433-6. PubMed ID: 7585090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.
    Gómez RM; Castagnino CG; Berría MI
    Int J Exp Pathol; 1992 Oct; 73(5):643-53. PubMed ID: 1329915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction.
    Okada I; Matsumori A; Kyu B
    Int J Exp Pathol; 1992 Dec; 73(6):721-31. PubMed ID: 1337265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.
    Kiel RJ; Smith FE; Chason J; Khatib R; Reyes MP
    Eur J Epidemiol; 1989 Sep; 5(3):348-50. PubMed ID: 2551723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.
    Van Houten N; Bouchard PE; Moraska A; Huber SA
    J Virol; 1991 Mar; 65(3):1286-90. PubMed ID: 1847455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
    Khatib R; Reyes MP; Khatib G; Giraldo A
    Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial injury occurs earlier than myocardial inflammation in acute experimental viral myocarditis.
    Lim BK; Shin JO; Choe SC; Choi SW; Jeong JO; Seong IW; Kim DK; Jeon ES
    Exp Mol Med; 2005 Feb; 37(1):51-7. PubMed ID: 15761252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of virus-induced myocardial injury in mice: value of the scid mutation on different genetic backgrounds and combined with other mutations.
    Chow LH
    Lab Anim Sci; 1993 Apr; 43(2):133-5. PubMed ID: 8391609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental myocarditis induced by two different coxsackievirus B3 variants: aspects of pathogenesis and comparison of diagnostic methods.
    Arola A; Kalimo H; Ruuskanen O; Hyypiä T
    J Med Virol; 1995 Nov; 47(3):251-9. PubMed ID: 8551277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
    Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
    J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign human enterovirus becomes virulent in selenium-deficient mice.
    Beck MA; Kolbeck PC; Rohr LH; Shi Q; Morris VC; Levander OA
    J Med Virol; 1994 Jun; 43(2):166-70. PubMed ID: 8083665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice.
    Beck MA; Kolbeck PC; Rohr LH; Shi Q; Morris VC; Levander OA
    J Nutr; 1994 Mar; 124(3):345-58. PubMed ID: 8120653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of verapamil on acute coxsackievirus B3 murine myocarditis.
    Xu Y; Yang YZ; Chen HZ; Jin PY; Guo Q; Zhao WZ; Yang JH; Cai QX; Zhou YC
    Chin Med J (Engl); 1992 Oct; 105(10):818-21. PubMed ID: 1337875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
    Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
    Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.